Current Clinical Investigations
Myristol® Clinical Study for Dogs
Myristol® is a combination of 4 joint health ingredients: an omega-5 fatty acid (cetyl myristoleate), glucosamine HCl, MSM, and a mixture of individual and short chain amino acids (hydrolyzed collagen). Each ingredient supports joint health in its own unique way. The combination of ingredients was selected with this comprehensive approach in mind. Based on the clinical data in horses, the Myristol® study is designed to determine its usefulness and efficacy in dogs with osteoarthritis.
This is a double-blinded , randomized, placebo controlled study. This means that dogs are randomly assigned to a received the active Myristol® or a placebo but neither the owner nor the evaluator know which one. This “blinding” allows objective evaluation without bias of knowing the actual treatment.
To be eligible for this study dogs must meet the following criteria:
•Lameness of ONLY KNEE or HIP at least 3 months duration with NSAID(Rimadyl®. Derramax®, Metacam®, Zubrin®, Previcox®) therapy and INCOMPLETE alleviation of pain
•Radiographs verifying osteoarthritis within last six months (we can repeat these if necessary)
•No significant blood cell or biochemical abnormalities
•No urinary abnormalities
•No long acting corticosteroid within 8 weeks of entering study
Benefits to Clients:
•Complete orthopedic evaluation
•Complete blood count free of charge
•Complete biochemical profile free of charge
•Analgesia medication (approved for use in dogs) for 56 days free of charge
•Helping other dogs live more comfortably with osteoarthritis
Owners must be willing to bring in their dogs on a schedule 4 times over a 70 day period.
If you are interested in having your dog participate in the Myristol® study, please call us at 719-266-6400
